“I believe that science and strategy must move together—because innovation alone is not enough unless it meets the right audience, at the right time, through the right message.”
Craig A. Parnell stands at the intersection of science, strategy, and storytelling. A trailblazing executive with over 43 years of experience in pharmaceutical sales and marketing, Craig has continually shaped the evolving landscape of global healthcare communications. His career journey reflects not just a series of impressive titles and high-profile achievements, but an enduring commitment to redefining how science reaches the world through digital transformation, patient-centered strategies, and collaborative leadership. As the CEO and President of CAP Pharma, Craig brings unmatched depth in omni/multi-channel marketing, analytics, and executive advisory to some of the world’s most respected pharmaceutical brands.
Craig’s trajectory into the upper echelons of the industry began in the early 1980s after completing his studies in communications at Ramapo College of New Jersey and later earning his M.A. in Communication Arts from William Paterson University. His early work at Merck & Co., where he developed interactive touchscreen tools and robotic simulator programs for physician education, was a strong indication of his passion for innovation and user-centered technology in healthcare. Even at this formative stage, he worked alongside top-level leadership, including then-CEO Roy Vagelos, laying the groundwork for a career centered around strategic vision and impactful execution.
His transition to Johnson & Johnson marked a significant inflection point. Over a 12-year tenure, Craig led internet and multimedia communications, pioneering some of the earliest digital health campaigns. From launching the first TV ad-supported website for Ortho Tri-Cyclen to initiating a women’s health digital community on iVillage with over two million registered users, Craig consistently leveraged emerging platforms to connect with patients and healthcare professionals. His efforts contributed to billions in sales and earned recognition for driving one of the most forward-thinking digital strategies in pharmaceutical marketing history.
As he advanced into global leadership roles, Craig took on the helm of Global eMarketing for Novartis Oncology, where he directed teams across continents to develop award-winning strategies for blockbuster drugs like Glivec, Zometa, Femara, and Exjade. He revolutionized Novartis’ digital presence with the first suite of international brand sites and patient portals, ensuring compliance, data integrity, and physician engagement in regions as diverse as Germany, the U.S., and emerging European markets. His work helped create scalable models for HCP engagement that drove measurable ROI and increased market penetration.
Craig’s agency-side experience further broadened his strategic capabilities. At EURO RSCG Life Chelsea, he led the Oncology team in launching Revlimid for Celgene, managing multi-million-dollar campaigns and over 60 distinct marketing tactics. He was instrumental in building long-term business plans for the oncology portfolio, reflecting his skill in both tactical execution and strategic foresight. His unique perspective—having sat on both the corporate and agency sides—makes him a highly versatile leader who can fluently speak the languages of brand, science, sales, and stakeholder value.
His entrepreneurial spirit led to the founding of CAP Pharma, a full-service marketing consultancy focused on pharmaceutical innovation. Under Craig’s leadership, CAP Pharma has helped launch Imbruvica for J&J and Pharmacyclics, develop digital and AI-driven adherence programs for telehealth startups, and win significant business with companies like Novartis, Teva, and Astellas. Craig’s model—centered on actionable strategy, precision marketing, and client empathy—has drawn praise from biotech and pharma partners alike, particularly mid-sized companies seeking experienced guidance without the overhead of larger firms.
In addition to his consultancy, Craig has served in senior business development roles with HealthLink Dimensions, Victory Healthcare Communications, and RxMx, where he sold AI-based patient monitoring solutions to life science organizations. At each step, he applied his signature blend of strategic empathy, data insight, and sales acumen. His engagements often begin with a single strategic one-pager—a document that synthesizes a company’s challenges, goals, and proposed tactics—demonstrating his belief that clarity is the cornerstone of communication.
Throughout his career, Craig has been a thought leader in omnichannel marketing, digital health, and organizational development. He’s spoken at conferences, contributed to publications, and been recognized with honors like the 2023 Health 2.0 Outstanding Leadership Award. In 2025, he was selected as a finalist for the Visionaries Award, reflecting not only his past achievements but his continued relevance and forward-thinking mindset in an industry marked by rapid transformation.
His impact is truly global. Craig’s work has taken him across Europe, and he has maintained professional ties in Belgium, where many of his international marketing initiatives began. His fluency in global business culture and experience navigating cross-border pharmaceutical strategy make him an ideal contributor to boards and advisory roles with international reach. While he remains based in New Jersey, Craig’s influence extends far beyond domestic borders.
Beyond business, Craig’s life reflects his values—discipline, mentorship, and service. Once a certified Level 1 ski instructor and a former Chaplain, he brings a deep sense of personal purpose to his professional journey. His work with the American Society of Hematology and passion for healthcare access and patient advocacy underscore his belief that marketing is not just about products, but about people. He views each campaign not just as a sales effort, but as an opportunity to improve outcomes and elevate human potential.
Character:
Craig demonstrates unwavering integrity and purpose in every professional engagement. His diverse background—from executive leadership to grassroots patient education—reflects a values-driven approach centered on impact and empathy. Whether leading teams or mentoring emerging talent, he cultivates trust, respect, and lasting relationships.
Knowledge:
With over four decades of experience, Craig possesses encyclopedic knowledge of pharmaceutical marketing, digital health, and global strategy. He has successfully launched numerous high-profile products across therapeutic areas, leveraging both data and instinct. His academic and professional journey reinforces a lifelong commitment to learning and industry leadership.
Strategic:
Craig’s success lies in his ability to see both the forest and the trees. He builds long-term vision through practical milestones and knows how to translate complex challenges into executable strategies. His clients value his rare ability to fuse high-level thinking with precise, results-driven action.
Communication:
At the heart of Craig’s impact is his gift for communication. Whether addressing executives, clinicians, or patients, he speaks with clarity, passion, and relevance. He crafts narratives that don’t just inform—they inspire, drive change, and build lasting brand equity.
